Adtalem Global Education (NYSE:CVSA) CEO Stephen Beard Sells 15,874 Shares of Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 15,874 shares of Adtalem Global Education stock in a transaction on Friday, May 8th. The shares were sold at an average price of $131.25, for a total value of $2,083,462.50. Following the sale, the chief executive officer directly owned 429,324 shares of the company’s stock, valued at $56,348,775. This represents a 3.57% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Down 1.5%

NYSE CVSA opened at $128.28 on Wednesday. The company’s 50-day moving average price is $112.44. Adtalem Global Education Inc. has a twelve month low of $86.97 and a twelve month high of $156.26. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36. The stock has a market capitalization of $4.37 billion, a P/E ratio of 19.98, a price-to-earnings-growth ratio of 1.08 and a beta of 0.63.

Adtalem Global Education (NYSE:CVSA) last released its quarterly earnings results on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25. The business had revenue of $487.03 million for the quarter. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The company’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.92 EPS. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, equities analysts expect that Adtalem Global Education Inc. will post 8.03 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have commented on CVSA. Wall Street Zen downgraded Adtalem Global Education from a “buy” rating to a “hold” rating in a research note on Saturday. Zacks Research downgraded Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 25th. Barrington Research reiterated an “outperform” rating and set a $170.00 target price on shares of Adtalem Global Education in a research note on Friday, April 17th. Truist Financial increased their target price on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday. Finally, Weiss Ratings began coverage on Adtalem Global Education in a research note on Wednesday, February 25th. They set a “hold (c+)” rating on the stock. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.